Kazia Therapeutics (KZIA) Non-Current Assets (2009 - 2025)
Kazia Therapeutics' (KZIA) quarterly Non-Current Assets came in at $739642.8 in Q4 2025, down 92.2% YoY from $9.5 million in Q4 2024, and up 2.52% on a QoQ basis from $721458.3 in Q2 2025.
Kazia Therapeutics (KZIA) Non-Current Assets (2009 - 2025) Analysis & Trends
Kazia Therapeutics (KZIA) has 17 years of Non-Current Assets data on file, last reported at $739642.8 in Q4 2025.
- Quarterly Non-Current Assets fell 92.2% year-over-year to $739642.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $739642.8 (down 92.2% YoY) and the FY2025 annual result came in at $721458.3, down 92.91% from the prior year.
- Non-Current Assets rose to $739642.8 in Q4 2025, from $721458.3 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $22.1 million in Q2 2021 to a low of $721458.3 in Q2 2025.
- A 5-year average of $11.9 million and a median of $11.1 million in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2021 — Non-Current Assets jumped 168.27% — and 2025, when it slumped 92.91%.
- Tracing KZIA's Non-Current Assets over 5 years: stood at $20.4 million in 2021, then decreased by 29.3% to $14.4 million in 2022, then fell by 25.98% to $10.7 million in 2023, then decreased by 11.01% to $9.5 million in 2024, then tumbled by 92.2% to $739642.8 in 2025.
- The last three Non-Current Assets figures came in at $739642.8 (Q4 2025), $721458.3 (Q2 2025), and $9.5 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | 739,642.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 739,642.85 |
| Jun 30, 2025 | 721,458.25 |
| Dec 31, 2024 | 9.49 Mn |
| Jun 30, 2024 | 10.18 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Jun 30, 2023 | 11.57 Mn |
| Dec 31, 2022 | 14.40 Mn |
| Jun 30, 2022 | 18.94 Mn |
| Dec 31, 2021 | 20.37 Mn |
| Jun 30, 2021 | 22.10 Mn |
| Dec 31, 2020 | 13.92 Mn |
| Jun 30, 2020 | 8.24 Mn |
| Dec 31, 2019 | 8.85 Mn |
| Jun 30, 2019 | 9.57 Mn |
| Dec 31, 2018 | 12.04 Mn |
| Jun 30, 2018 | 14.32 Mn |
| Jun 30, 2017 | 12.34 Mn |
| Dec 31, 2016 | 17.30 Mn |
| Jun 30, 2016 | 12.27 Mn |
| Dec 31, 2015 | 1.07 Mn |